SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Actinium Pharmaceuticals, Inc. (ATNM) News

Follow Actinium Pharmaceuticals, Inc. (ATNM) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ATNM Asset equity Sector Markets 90 days 2 Last 1.08 Updated Oct 19, 2026, 11:30 AM UTC Open live news feed Open ATNM chart & news
L Actinium Pharmaceuticals to present ATNM-400 data at EANM 2026 The company plans to present first-in-human clinical data in prostate cancer and preclinical lung cancer results today. EQUITY | Oct 19, 2026, 11:30 AM UTC L ATNM - Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference ATNM - Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference EQUITY | Sep 04, 2026, 09:05 PM UTC L Actinium Pharmaceuticals updates Actimab-A IP, manufacturing and NYSE listing Actinium Pharmaceuticals (ATNM) announces Actimab-A intellectual property and manufacturing advances and provides an update on its NYSE American listing. MNA | Aug 14, 2026, 09:02 PM UTC